Is there a role for vaccines in combatting the opioid epidemic?

Fentanyl is at the center of the opioid crisis in the USA, causing an increasing number of overdoses and deaths. Casey Nevins, Assistant Editor, Vaccine Insights, speaks with Elizabeth Norton, Associate Professor, Tulane School of Medicine, about her work in developing a mucosal vaccination tailored to protect the brain from the effects of fentanyl.

• Publication year

  2024

• Venue

  Vaccine Insights

• Publication date

  2024-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.18609/vac.2024.017PMID 39156761PMCID 11329228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in enterotoxin vaccine adjuvants.

  2023cited by this paper
• An Immunconjugate Vaccine Alters Distribution and Reduces the Antinociceptive, Behavioral and Physiological Effects of Fentanyl in Male and Female Rats

  2022cited by this paper
• Anti-Cocaine IgA Rather Than IgG Mediates Vaccine Protection from Cocaine Use

  2022cited by this paper
• Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge

  2021cited by this paper
• Gut-educated IgA plasma cells defend the meningeal venous sinuses

  2020cited by this paper
• Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose

  2018cited by this paper
• The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT

  2018cited by this paper
• Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial.

  2014cited by this paper

• No citing papers are available for this paper.